Philippe Menu is an individual and currently serves as EVP, Chief Product Officer and Chief Medical Officer at SOPHiA GENETICS; he previously held the role of Chief Medical Officer after joining the company in February 2020.( SOPHiA GENETICS described him as bringing a blend of clinical medicine, molecular biology research, and business management consulting experience to the company.(

Before SOPHiA GENETICS, Menu spent eight years at McKinsey & Company, advising biopharma clients across the life sciences value chain, with a focus on oncology and rare diseases.( He earned an MD and PhD from the University of Lausanne and an MBA in life sciences from the Open University Business School.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.